Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive Ballard

Showing results (371-380 of 480) with videos related to

Pageof 48
Sort By:
Trials|July 14, 2014
Improving Well-being and Health for People with Dementia (WHELD): study protocol for a randomised controlled trialRhiannon Whitaker, Jane Fossey, Clive Ballard, et al.
BMJ (Clinical Research Ed.)|February 22, 2005
Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trialClive Ballard, Marisa Margallo-Lana, Edmund Juszczak, et al.
Nature and Science of Sleep|January 15, 2021
Striatal Dopaminergic Deficit and Sleep in Idiopathic Rapid Eye Movement Behaviour Disorder: An Explorative StudyDanielle Wasserman, Dorothea Bindman, Alexander D Nesbitt, et al.
BMC Geriatrics|August 4, 2022
Attitudes toward own aging and cognition among individuals living with and without dementia: findings from the IDEAL programme and the PROTECT studySerena Sabatini, Anthony Martyr, Obioha C Ukoumunne, et al.
Nature Communications|May 6, 2026
Alzheimer's Disease blood biomarkers measured through remote capillary sampling correlate with cognition in older adultsAnne Corbett, Millie Sander-Long, Nicholas J Ashton, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 22, 2020
FLAME: A computerized neuropsychological composite for trials in early dementiaHelen Brooker, Gareth Williams, Adam Hampshire, et al.
Current Alzheimer Research|January 11, 2018
(-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's DiseaseRobert E Becker, Nigel H Greig, Debomoy K Lahiri, et al.
Neurobiology of Aging|August 9, 2014
Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairmentDavid R Whitfield, Julie Vallortigara, Amani Alghamdi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 1, 2022
Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registersCaroline Holm Nørgaard, Sarah Friedrich, Charlotte Thim Hansen, et al.
Nature Aging|December 19, 2025
Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disordersMarwan N Sabbagh, Jeffrey L Cummings, Clive Ballard, et al.
Pageof 48

Showing results (371-380 of 480) with videos related to

Sort By:
Pageof 48
Trials|July 14, 2014
Improving Well-being and Health for People with Dementia (WHELD): study protocol for a randomised controlled trialRhiannon Whitaker, Jane Fossey, Clive Ballard, et al.
BMJ (Clinical Research Ed.)|February 22, 2005
Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trialClive Ballard, Marisa Margallo-Lana, Edmund Juszczak, et al.
Nature and Science of Sleep|January 15, 2021
Striatal Dopaminergic Deficit and Sleep in Idiopathic Rapid Eye Movement Behaviour Disorder: An Explorative StudyDanielle Wasserman, Dorothea Bindman, Alexander D Nesbitt, et al.
BMC Geriatrics|August 4, 2022
Attitudes toward own aging and cognition among individuals living with and without dementia: findings from the IDEAL programme and the PROTECT studySerena Sabatini, Anthony Martyr, Obioha C Ukoumunne, et al.
Nature Communications|May 6, 2026
Alzheimer's Disease blood biomarkers measured through remote capillary sampling correlate with cognition in older adultsAnne Corbett, Millie Sander-Long, Nicholas J Ashton, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 22, 2020
FLAME: A computerized neuropsychological composite for trials in early dementiaHelen Brooker, Gareth Williams, Adam Hampshire, et al.
Current Alzheimer Research|January 11, 2018
(-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's DiseaseRobert E Becker, Nigel H Greig, Debomoy K Lahiri, et al.
Neurobiology of Aging|August 9, 2014
Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairmentDavid R Whitfield, Julie Vallortigara, Amani Alghamdi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 1, 2022
Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registersCaroline Holm Nørgaard, Sarah Friedrich, Charlotte Thim Hansen, et al.
Nature Aging|December 19, 2025
Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disordersMarwan N Sabbagh, Jeffrey L Cummings, Clive Ballard, et al.
Pageof 48